Your Cart
Loading

Bixafen Patent Landscape Analysis

On Sale
$750.00
Pay what you want: (minimum $750.00)
$
Added to cart

Bixafen is an SDHI fungicide developed by Bayer, commercialised through products such as Aviator® Xpro.

The retained landscape covers 177 patent families across 67 consolidated owner groups. Combination is the thickest protection layer (109 families), with single-active formulation providing additional constraint.

139 of the 177 retained families carry a grant or national pending reading. 76 families are held by China-based applicants; thirty-nine live families have a nominal term ending within five years. Position as at October 2026.

This 65-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.

You will get a PDF (2MB) file

Customer Reviews

There are no reviews yet.